ArticleFrontiers in oncology2022

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.

Michael Stadler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.